Skip to main content
. 2019 Oct 15;49(11):1475–1486. doi: 10.1111/cea.13485

Table 1.

Characteristics of the study populations in ALSPAC and MAAS cohorts

Characteristics Study sampled Excluded sample (no data on outcome and/or genetics) P‐valuec
N with characteristic (%) Total N N with characteristic (%) Total N
ALSPAC
Gender (male) 3244 (51.1) 6345 4375 (51.6) 8479 0.575
Lower combined social classa 2617 (43.9) 5957 3017 (54.4) 5547 3.54E‐29
Lower maternal educational levelb 3577 (57.5) 6220 4466 (71.8) 6218 1.31E‐62
Allergic diseases latent classese
No Disease 3175 (50.0) 6345 1150 (49.8) 2309 (Reference)
Atopic March 175 (2.8) 59 (2.5) 0.621
Persistent eczema and wheeze 181 (2.9) 72 (3.1) 0.508
Persistent eczema with late‐onset rhinitis 307 (4.8) 111 (4.8) 0.991
Persistent wheeze with late‐onset rhinitis 348 (5.5) 149 (6.5) 0.107
Transient wheeze 534 (8.4) 195 (8.4) 0.939
Eczema only 948 (15.0) 323 (14.0) 0.394
Rhinitis only 677 (10.7) 250 (10.8) 0.820
MAAS
Gender (male) 482 (53.8) 896 186 (55.7) 287 0.305
Lower combined social classa 225 (36.9) 610 60 (43.2) 139 0.101
Lower maternal educational levelb 359 (55.3) 649 45 (57.7) 78 0.392
Allergic diseases latent classese
No Disease 322 (35.9) 896 87 (38.9) 223 (reference)
Atopic March 55 (6.1) 11 (5.1) 0.471
Persistent eczema and wheeze 46 (5.1) 10 (4.6) 0.611
Persistent eczema with late‐onset rhinitis 73 (8.1) 18 (7.9) 0.710
Persistent wheeze with late‐onset rhinitis 81 (9.0) 18 (8.2) 0.557
Transient wheeze 65 (7.3) 15 (6.8) 0.644
Eczema only 141 (15.7) 34 (15.3) 0.634
Rhinitis only 114 (12.8) 29 (13.1) 0.836
a

Mother and partner level of occupation (manual vs non‐manual) in ALSPAC, combined socio‐economic status (not working, routine, intermediate vs managerial) in MAAS.

b

In ALSPAC, mother educated to the General Certificate of Education level (school‐leaving certificate) or lower; In MAAS, mother not educated to UK A or As level (data from follow‐up questionnaire at 13‐16 y).

c

P‐values are from chi‐squared test for binary variables and logistic regression for latent variables (baseline group is “no disease” class), comparing “included” vs “excluded” individuals.

d

Participants with SNP data and outcome data available.

e

Proportions were weighted by posterior membership probabilities.